MediConnect

MediConnect

Created using Figma
Created using Figma
MediConnect is the only blockchain solution intended to revolutionise the use of medication in the UK. It will prevent the over-prescribing to patients of medication from multiple pharmacies, reduce addiction, provide traceability of drugs from manufacturers, wholesalers, prescribers and pharmacies all the way through to patients. This will enable the removal of false medicines and the easy recall of drugs within the Pharma system.
ICO
Feb 20, 2019
Apr 3, 2019
100% completed
Raised funds - no Data
past
Private sale
Jan 16, 2019
Feb 6, 2019
100% completed
Raised funds - no Data
Goal 10 000 000.00 USD
past
Token Details
Ticker
MEDI
Accepted Currencies
BTC, STRAT
Company Details
Registered Country
United Kingdom
Additional Details
KYC
Yes
Categories
Platform

About MediConnect

The Safety Net for Patients, Prescribers, Pharmacies and Drug Manufacturers.

With all the regulatory bodies within the Pharmacy sector recognising and concerned about the growing issue of over-prescribing of prescription medication online, MediConnect can offer a solution to this growing problem almost immediately.

Prescribers & pharmacies using MediConnect will have the confidence that by using our blockchain solution, the misuse and over-prescribing of prescription medication to potential addicts – who would normally shop around online for medication – will be eliminated.

Patients will be given the assurance that the medication they are being prescribed is genuine and from a licensed manufacturer, prescriber and pharmacy that is using a gold-standard solution to help improve their own duty of care.

MediConnect Roadmap

  • Q1 2018

  • Conceived Idea and scoped out requirements of a Prescription Drug Addiction Database.
  • Q2 2018

  • Agreed blockchain platform partnership with Stratis.
  • Q3 2018

  • Presented idea of a regional trial of East Midlands Pharmacies with newly formed Nottingham Addiction Safeguarding Committee.
  • Q4 2018

  • Jason Timms appointed chair of the official Prescription Drug Addiction (PDA) Working Group with the BBFA to tackle over prescribing, drug recalls, counterfeit drug reduction.
    Agreed contract start date with ASC Nottingham for Q2 2019 and the onboarding of 2 Pharmacies to MediConnect.
    Attended all Chairperson Meeting of the BBFA working groups to look at collaborative opportunities of the PDA on legal, identity, master data, assurance and Cybersecurity working groups.
  • Read More
  • Q1 2019

  • ICO Public Sale.
    PDA Working Group meeting – Invites to attend to CQC, MHRA, GPhC, LPC, Pharma wholesale and retail industry.
  • Q2 2019

  • Commence contract with the ASC to support the Nottingham Trial and UK roll out programme.
    Tower Pharmacy & UK Meds will be first 2 Pharmacies on the ASC blockchain solution from MediConnect.
    6 other Pharmacies will be integrated, including 1 NHS Hospital outpatient dispensing pharmacy.
  • Q3 2019

  • Collaboration with Local Pharmacy Groups and membership committee to inform on pilot and expand reach to 20 further pharmacies in Nottingham, Derby & Leicester.
    Partnership with Pharmacy Wholesaler – implementation of drug recall and counterfeit medication system.
  • Q4 2019

  • Publish trial research and outcomes – present at PDA meeting to CQC, MHRA. GPhC, LPC and Industry.
  • Q1 2020

  • The MediConnect platform will demonstrate an improved duty of care and detection that will see a reduction in pharmacy insurance for Pharmacies.
  • Q2 2020

  • Will see the recruitment of 500 UK Pharmacies join MediConnect through the expansion of the ASC membership in the UK.
  • Q3 2020

  • Aim for MediConnect to be the Industry standard solution for traceability of drugs for recall and counterfeit medication detection.
  • Q4 2020

  • The ASC achieves it’s goal of UK Pharmacies required to be members of the ASC and the MediConnect platform is used by all UK pharmacies

Activity

Activity:
7
VERY LOW
Posts:
19
VERY LOW
Views:
352
VERY LOW
Posts:
176
MEDIUM
Followers:
3 949
MEDIUM
Likes:
3 929
MEDIUM
Rating:
5
VERY HIGH
Followers:
3 246
MEDIUM
Tweets:
297
MEDIUM
30 Days Growth:
-26
Members:
4 154
MEDIUM
30 Days Growth:
-41

MediConnect Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Bobby Cato
Project manager
unverified
Dexter Blackstock
Mediconnect Director
unverified
Joe Soiza
UK Meds Owner and Healthcare Visionary
unverified
Jason Timms
PHZ Group Owner & Visionary
unverified
Chris Trew
CEO and Founder of Stratis Group Ltd
unverified
Shyam Morjaria
Superintendent Pharmacist & Head of Purchasing
unverified
Eddie Dandy
Superintendent Pharmacist
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Samuel Ogunsalu
Advisor
unverified

MediConnect Last News

N/A
5.0 11
ICO Profile Vision Activity Potential Product Team
  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.
Planning an ICO? We can help with a wide range of support for all stages of your ICO